Skip to main content

Table 1 Patient characteristics and ME status

From: Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy

  Patients ME positive  
Characteristic No (%) % P value
Age (y)    NS
   ≤60 39 (51.3) 87.2  
   >60 37 (48.7) 73.0  
Sex    NS
   Male 60 (78.9) 78.3  
   Female 16 (21.1) 87.5  
Status of Hepatitis    
   HBsAg positive 62 (81.6) 85.5 NS
   HCVAb positive 3 (3.9) 33.3  
   Others 11 (14.5) 63.6  
AFP level (ng/ml)    <0.01
   Normal 43 (56.6) 69.8  
   Elevated 33 (43.4) 93.9  
Tumor size (cm)    NS
   ≤5 41 (53.9) 78.0  
   >5 35 (46.1) 82.9  
TNM stage    NS
   I 42 (55.3) 83.3  
   II 34 (44.7) 76.5  
Platelets (G/L)    NS
   <100 11 (14.5) 81.8  
   ≥100 65 (85.5) 80.0  
AST level (U/L)    NS
   ≤40 54 (71.1) 85.2  
   >40 22 (28.9) 68.2  
ALT level (U/L)    NS
   ≤40 49 (71.1) 81.6  
   >40 27 (28.9) 77.8  
GGT level (U/L)    NS
   ≤55 43 (56.6) 81.4  
   >55 33 (43.4) 78.8  
Albumin level(g/L)    NS
   ≤35 8 (10.5) 75.0  
   >35 68 (89.5) 80.9  
BIL (μmol/L)    NS
   ≤17.1 59 (77.6) 78.0  
   >17.1 17 (22.4) 88.2  
PT(s)    NS
   ≤13.3 55 (72.4) 83.6  
   >13.3 21 (27.6) 71.4  
Tumor grade    <0.01
   1 6 (7.9) 16.7  
   2 43 (56.6) 79.1  
   3 27 (35.5) 96.3  
All patients 76 (100) 80.3 --
  1. Abbreviations: HBsAg = hepatitis B surface antigen; HCV Ab = hepatitis C virus antibody; AFP = serum α-fetoprotein; AST = serum aspartate aminotransferase level; ALT = serum alanine aminotransferase level; GGT = serum γ-glutamyltransferase; BIL = serum total bilirubin level; PT = prothrombin time; NS = not significant.